Drug interaction between antiretrovirals and psychodrugs
DOI:
https://doi.org/10.33448/rsd-v11i11.32576Keywords:
Drug interactions; Anti-HIV Drugs; Drug incompatibility.Abstract
Introduction: The human immunodeficiency virus type 1 (HIV-1) is the agent that produces AIDS, a disease recognized for more than forty years, which has reached pandemic proportions. Its origin dates back to the transmission to humans of retroviruses that infected populations of chimpanzees in central Africa approximately 100 years ago. From this location, its expansion to the whole world has been enormous, mainly in the last decades. Objectives: to carry out a literature review on the drug interaction between antiretrovirals and psychotropic drugs, identifying the factors that influence the consumption of psychotropic drugs in people with HIV. Method: Qualitative research, such as an integrative literature review, with data collected through articles available on online platforms. Results: The results obtained already published may be controversial, since some authors interpret certain adverse reactions as not resulting from drug interaction, but caused by the antidepressant, antipsychotic and antiretroviral drug itself, that is, the observation of effects side effects, which may be related both to the interaction of different classes of antiretrovirals and to that of antidepressants and antipsychotics with antiretrovirals, make it difficult to characterize the interaction and, therefore, this observation is often neglected. Conclusion: Despite the studies analyzed demonstrate effects between drug interactions (retrovirals and psychotropic drugs, research with a greater number of individuals should be developed.
References
Amodeo, D. A., Yi, J., Sweeney, J. A. & Ragozzino, M. E. (2014) Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf/J mice. Front Synaptic Neurosci 6:17.
Baer, L., Trivedi, M. H., Huz, I., Rush, A. J, Wisniewski, S. R. & Fava, M. (2015). Prevalence and impact of obsessive-compulsive symptoms in depression. J Clin Psychiatry.
Brasil. (2018). Ministério da Saúde. Boletim de Aids e DST HIV/Aids 2018. Publ. 27/11/2018.
Galvão, C. M. (2002). A prática baseada em evidências: uma contribuição para a melhoria da assistência de enfermagem perioperatória. [livre-docência]. Ribeirão Preto (SP): Escola de Enfermagem de Ribeirão Preto/USP
Gonzalez-Torres, M. A., Salazar, M. A., Imaz, M. et al. (2014), Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors. Neuropsychiatr Dis Treat
Goodlet, K. J., Zmarlicka, M. T. & Peckham, A. M. (2019). Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs CNS
Hoefler R. (2015). Drug Interactions. Secr Ciência, Tecnol e Insumos Estratégicos/MS - FTN. 35(1):28–34
Kitchenham, B. A. (2020). Procedures for performing systematic reviews. Software Engineering Group – Keele University – United Kingdom and Empirical Software Engineering, National ICT Australia. 2004.
Lima, L. G. B. et al. (2020) Características de usuários com diagnóstico de Transtorno Depressivo atendidos em um Centro de Atenção Psicossocial. Rev. Eletrônica Saúde Mental Álcool Drog
Mills, J. C., Harman, J. S., Cook, R. L., Marlow, N. M., Harle, C. A., Duncan, R, P. et al. (2017). Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression. AIDS
Moura C, Acurcio F, & Belo N. (2009) Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 12(3):266–72. 88.
Ostad Haji E, Hiemke C, & Pfuhlmann B. (2012) Therapeutic drug monitoring for antidepressant drug treatment. Curr Pharm Des 2012; 18:5818–5827.
Oviedo-Joekes E, et al. (2009) Uso y valoración de los servicios sanitarios y de la medicación antirretroviral en personas diagnosticadas de infección por el virus de la inmunodeficiencia humana [Use and evaluation of the health care services and the antirretroviral medication in HIV diagnosed people]. 23(2):121-6.
Reis, H. P. L. C. (2014) Acompanhamento de pessoas com HIV sob terapia antirretroviral: adequação, aplicação e avaliação de indicadores clínico-laboratoriais, farmacoterapêuticos e humanísticos na atenção farmacêutica. 395 f. Tese (Doutorado) – Universidade Federal do Ceará, Departamento de Farmácia, Programa de Pós-Graduação em Ciências Farmacêuticas, Doutorado em Ciências Farmacêuticas, Fortaleza, 2014.
Sampieri, R. H., et al. (2013) Metodologia de Pesquisa. São Paulo: Mc-Graw-Hill, (5a ed.).
Santos, W. M.; Secoli, S. R.; & Padoin, S. M. M. (2016) Potenciais interações de drogas em pacientes de terapia antirretroviral. Revista Latino-Americana de Enfermagem, v. 24, n. 1, p. 1-9, 2016.
Thompson A, Silverman B, Dzeng L, & Treisman G. (2006) Psychotropic medications and HIV. Clin Infect Dis. 42(9):1305-10. 10.1086/501454.
Tseng, A.; et al. (2013) Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother, 47, 1429-1439.
Van Mil, J. W. F.; et al. (2016) Medical Care and Drug – related problems: ¿do doctors and pharmacists speak the same language? Int J Clin Pharm, 38, 191-194
Whittemore R, Knafl K. The integrative review: update methodology. J Adv Nurs. 2005;52(5):546-53.
Zirulnik J. L. (2015) Actualización en el manejo de psicofármacos en pacientes VIH positivos [Management of psychotropic drugs in hiv-infected patients]. 2015 26(121):217-23. Spanish.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Andreia Ribeiro Mota; Fabiana Schuelter-Trevisol
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
